CYTOMX THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months High: CYTOMX THERAPEUTICS INC. - COMMON STOCK

27 2 2024 11:18:02 提供 NetDania Notify

CytomX Therapeutics to Present at Upcoming March Investor Conferences

27 2 2024 07:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b

24 1 2024 07:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference

12 1 2024 07:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Outlines 2024 Company Priorities and Milestones

04 1 2024 07:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

21 12 2023 07:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

07 11 2023 15:15:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming November Investor Conferences

01 11 2023 07:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics to Report Third Quarter 2023 Financial Results on November 7, 2023

31 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Interferon Alpha-2b at the SITC 2023 Annual Meeting

30 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Presents Preclinical Profile of EpCAM-directed Antibody Drug Conjugate CX-2051 at 2023 World ADC Conference

18 10 2023 15:30:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming September Investor Conferences

05 9 2023 15:05:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference

10 8 2023 15:05:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

08 8 2023 15:15:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics to Report Second Quarter 2023 Financial Results on August 8, 2023

01 8 2023 07:00:02 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Announces New Employment Inducement Grants

20 7 2023 08:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Appoints Yu-Waye (Wayne) Chu, M.D., as Chief Medical Officer

17 7 2023 07:00:01 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Announces $30 Million Private Placement from BVF Partners L.P.

30 6 2023 07:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the Jefferies Healthcare Conference

01 6 2023 15:05:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

09 5 2023 15:15:00 提供 Nasdaq GlobeNewswire